Q: What is Charles River Laboratories International, Inc.'s WACC?

Charles River Laboratories International, Inc. (CRL) has a Weighted Average Cost of Capital (WACC) of 7.86%. This is calculated using a Cost of Equity of 8.53% (via CAPM with a beta of 1.00) and a pre-tax Cost of Debt of 5.01%, with an equity weight of 80.94% in the capital structure.

Q: Is Charles River Laboratories International, Inc.'s WACC high or low?

Charles River Laboratories International, Inc.'s WACC of 7.86% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Q: How is Charles River Laboratories International, Inc.'s WACC calculated?

Charles River Laboratories International, Inc.'s WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 8.53% is derived from the CAPM model using a beta of 1.00. The pre-tax Cost of Debt (Rd) is 5.01%. The capital structure is 80.94% equity and 19.06% debt.

Question 1

What is Charles River Laboratories International, Inc.'s WACC?

Accepted Answer

Charles River Laboratories International, Inc.（CRL） WACC 解读

Charles River Laboratories International, Inc.（CRL）当前估算的 WACC 为 7.86%。其中股权成本为 8.53%，税前债务成本为 5.01%，股权权重为 80.94%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较低区间，通常意味着资本成本较低、估值折现压力更小。

Question 2

Is Charles River Laboratories International, Inc.'s WACC high or low?

Accepted Answer

Charles River Laboratories International, Inc.（CRL） WACC 解读

Charles River Laboratories International, Inc.（CRL）当前估算的 WACC 为 7.86%。其中股权成本为 8.53%，税前债务成本为 5.01%，股权权重为 80.94%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较低区间，通常意味着资本成本较低、估值折现压力更小。

Question 3

How is Charles River Laboratories International, Inc.'s WACC calculated?

Accepted Answer

Charles River Laboratories International, Inc.（CRL） WACC 解读

Charles River Laboratories International, Inc.（CRL）当前估算的 WACC 为 7.86%。其中股权成本为 8.53%，税前债务成本为 5.01%，股权权重为 80.94%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较低区间，通常意味着资本成本较低、估值折现压力更小。

Charles River Laboratories International, Inc. (CRL) — WACC 分析

WACC 构成

解读

Charles River Laboratories International, Inc.（CRL）WACC：7.86%

WACC计算器

Charles River Laboratories International, Inc.（CRL） WACC 解读

CRL 公司分析

CRL DCF 估值

继续做同行对比